These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. RNA interference (RNAi) in hematology. Scherr M; Steinmann D; Eder M Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462 [TBL] [Abstract][Full Text] [Related]
8. [RNA interference: from origins to a novel tool for gene silencing]. Ortiz-Quintero B Rev Invest Clin; 2009; 61(5):412-27. PubMed ID: 20184102 [TBL] [Abstract][Full Text] [Related]
9. Barriers to successful delivery of short interfering RNA after systemic administration. White PJ Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1371-6. PubMed ID: 18565190 [TBL] [Abstract][Full Text] [Related]
10. RNA interference: a tool for querying nervous system function and an emerging therapy. Davidson BL; Boudreau RL Neuron; 2007 Mar; 53(6):781-8. PubMed ID: 17359914 [TBL] [Abstract][Full Text] [Related]
11. Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference. Caplen NJ Gene Ther; 2004 Aug; 11(16):1241-8. PubMed ID: 15292914 [TBL] [Abstract][Full Text] [Related]
12. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy. Takahashi Y; Nishikawa M; Takakura Y Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274 [TBL] [Abstract][Full Text] [Related]
13. Control of HIV-1 replication by RNA interference. Lee NS; Rossi JJ Virus Res; 2004 Jun; 102(1):53-8. PubMed ID: 15068880 [TBL] [Abstract][Full Text] [Related]
14. Advances in cell-type specific delivery of RNAi-based therapeutics. Dykxhoorn DM IDrugs; 2010 May; 13(5):325-31. PubMed ID: 20432190 [TBL] [Abstract][Full Text] [Related]
15. Prospects of RNA interference therapy for cancer. Pai SI; Lin YY; Macaes B; Meneshian A; Hung CF; Wu TC Gene Ther; 2006 Mar; 13(6):464-77. PubMed ID: 16341059 [TBL] [Abstract][Full Text] [Related]
16. [Therapeutic RNA interference for neurodegenerative diseases]. González-Alegre P Rev Neurol; 2008 Dec 16-31; 47(12):641-7. PubMed ID: 19085881 [TBL] [Abstract][Full Text] [Related]
17. Nonviral in vivo delivery of therapeutic small interfering RNAs. Aigner A Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447 [TBL] [Abstract][Full Text] [Related]
18. RNA interference as an anticancer therapy: a patent perspective. Dykxhoorn DM Expert Opin Ther Pat; 2009 Apr; 19(4):475-91. PubMed ID: 19441927 [TBL] [Abstract][Full Text] [Related]
19. RNA interference and potential therapeutic applications of short interfering RNAs. Karagiannis TC; El-Osta A Cancer Gene Ther; 2005 Oct; 12(10):787-95. PubMed ID: 15891770 [TBL] [Abstract][Full Text] [Related]
20. RNA interference and its current application in mammals. Shen WG Chin Med J (Engl); 2004 Jul; 117(7):1084-91. PubMed ID: 15265387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]